267 related articles for article (PubMed ID: 34455072)
21. Targeting SARS-CoV-2 RNA-dependent RNA polymerase: An
Baby K; Maity S; Mehta CH; Suresh A; Nayak UY; Nayak Y
F1000Res; 2020; 9():1166. PubMed ID: 33204411
[No Abstract] [Full Text] [Related]
22. Drug repurposing strategies and key challenges for COVID-19 management.
Mule S; Singh A; Greish K; Sahebkar A; Kesharwani P; Shukla R
J Drug Target; 2022 Apr; 30(4):413-429. PubMed ID: 34854327
[TBL] [Abstract][Full Text] [Related]
23. Identifying SARS-CoV-2 Drugs Binding to the Spike Fatty Acid Binding Pocket Using In Silico Docking and Molecular Dynamics.
Piplani S; Singh P; Petrovsky N; Winkler DA
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835602
[TBL] [Abstract][Full Text] [Related]
24. Drug repurposing against SARS-CoV-2 using computational approaches.
Kumar S; Kovalenko S; Bhardwaj S; Sethi A; Gorobets NY; Desenko SM; Poonam ; Rathi B
Drug Discov Today; 2022 Jul; 27(7):2015-2027. PubMed ID: 35151891
[TBL] [Abstract][Full Text] [Related]
25. Combined deep learning and molecular docking simulations approach identifies potentially effective FDA approved drugs for repurposing against SARS-CoV-2.
Anwaar MU; Adnan F; Abro A; Khan RA; Rehman AU; Osama M; Rainville C; Kumar S; Sterner DE; Javed S; Jamal SB; Baig A; Shabbir MR; Ahsan W; Butt TR; Assir MZ
Comput Biol Med; 2022 Feb; 141():105049. PubMed ID: 34823857
[TBL] [Abstract][Full Text] [Related]
26. Drug repurposing approach to fight COVID-19.
Singh TU; Parida S; Lingaraju MC; Kesavan M; Kumar D; Singh RK
Pharmacol Rep; 2020 Dec; 72(6):1479-1508. PubMed ID: 32889701
[TBL] [Abstract][Full Text] [Related]
27. Repurposing Fostamatinib to Combat SARS-CoV-2-Induced Acute Lung Injury.
Tabassum N; Zhang H; Stebbing J
Cell Rep Med; 2020 Nov; 1(8):100145. PubMed ID: 33225317
[TBL] [Abstract][Full Text] [Related]
28. Drug repurposing for COVID-19 based on an integrative meta-analysis of SARS-CoV-2 induced gene signature in human airway epithelium.
Gupta RK; Nwachuku EL; Zusman BE; Jha RM; Puccio AM
PLoS One; 2021; 16(9):e0257784. PubMed ID: 34582497
[TBL] [Abstract][Full Text] [Related]
29. Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2-ACE2 Receptor Interactions.
Day CJ; Bailly B; Guillon P; Dirr L; Jen FE; Spillings BL; Mak J; von Itzstein M; Haselhorst T; Jennings MP
mBio; 2021 Mar; 12(2):. PubMed ID: 33785634
[TBL] [Abstract][Full Text] [Related]
30. SperoPredictor: An Integrated Machine Learning and Molecular Docking-Based Drug Repurposing Framework With Use Case of COVID-19.
Ahmed F; Lee JW; Samantasinghar A; Kim YS; Kim KH; Kang IS; Memon FH; Lim JH; Choi KH
Front Public Health; 2022; 10():902123. PubMed ID: 35784208
[TBL] [Abstract][Full Text] [Related]
31. Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease.
Kandeel M; Al-Nazawi M
Life Sci; 2020 Jun; 251():117627. PubMed ID: 32251634
[TBL] [Abstract][Full Text] [Related]
32. Repurposing drug molecule against SARS-Cov-2 (COVID-19) through molecular docking and dynamics: a quick approach to pick FDA-approved drugs.
Farhat N; Khan AU
J Mol Model; 2021 Oct; 27(11):312. PubMed ID: 34601658
[TBL] [Abstract][Full Text] [Related]
33. A Systematic Review of the Global Intervention for SARS-CoV-2 Combating: From Drugs Repurposing to Molnupiravir Approval.
Ashour NA; Abo Elmaaty A; Sarhan AA; Elkaeed EB; Moussa AM; Erfan IA; Al-Karmalawy AA
Drug Des Devel Ther; 2022; 16():685-715. PubMed ID: 35321497
[TBL] [Abstract][Full Text] [Related]
34. Repositioning Therapeutics for SARS-CoV-2: Virtual Screening of Plant-based Anti-HIV Compounds as Possible Inhibitors against COVID-19 Viral RdRp.
Murali M; Gowtham HG; Ansari MA; Alomary MN; Alghamdi S; Almehmadi M; Singh SB; Shilpa N; Aiyaz M; Kalegowda N; Ledesma AE; Amruthesh KN
Curr Pharm Des; 2022; 28(12):969-980. PubMed ID: 35796443
[TBL] [Abstract][Full Text] [Related]
35. The Anatomy of the SARS-CoV-2 Biomedical Literature: Introducing the CovidX Network Algorithm for Drug Repurposing Recommendation.
Gates LE; Hamed AA
J Med Internet Res; 2020 Aug; 22(8):e21169. PubMed ID: 32735546
[TBL] [Abstract][Full Text] [Related]
36. Computational drug repurposing study of antiviral drugs against main protease, RNA polymerase, and spike proteins of SARS-CoV-2 using molecular docking method.
Jalalvand A; Khatouni SB; Najafi ZB; Fatahinia F; Ismailzadeh N; Farahmand B
J Basic Clin Physiol Pharmacol; 2021 Jul; 33(1):85-95. PubMed ID: 34265888
[TBL] [Abstract][Full Text] [Related]
37. Ligand-based drug repurposing strategy identified SARS-CoV-2 RNA G-quadruplex binders.
Moraca F; Marzano S; D'Amico F; Lupia A; Di Fonzo S; Vertecchi E; Salvati E; Di Porzio A; Catalanotti B; Randazzo A; Pagano B; Amato J
Chem Commun (Camb); 2022 Oct; 58(85):11913-11916. PubMed ID: 36196950
[TBL] [Abstract][Full Text] [Related]
38. Vaccine development and therapeutic design for 2019-nCoV/SARS-CoV-2: Challenges and chances.
Ghaebi M; Osali A; Valizadeh H; Roshangar L; Ahmadi M
J Cell Physiol; 2020 Dec; 235(12):9098-9109. PubMed ID: 32557648
[TBL] [Abstract][Full Text] [Related]
39. In silico drug repurposing against SARS-CoV-2 using an integrative transcriptomic profiling approach: Hydrocortisone and Benzhydrocodone as potential drug candidates against COVID-19.
Mirmohammadi S; Kianmehr A; Sabbaghian A; Mohebbi A; Shahbazmohammadi H; Sheykharabi M; Bazzi Z
Infect Genet Evol; 2022 Sep; 103():105318. PubMed ID: 35718334
[TBL] [Abstract][Full Text] [Related]
40. COVID-19 challenges and its therapeutics.
Rehman SU; Rehman SU; Yoo HH
Biomed Pharmacother; 2021 Oct; 142():112015. PubMed ID: 34388532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
